Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1977-9-2
|
pubmed:abstractText |
Fifty preterm babies were randomly assigned to a group given oral bucolome (30 mg/kg per day for 5 days) and a control group. Serum bilirubin levels of the treated infants from day 4 onwards were consistently lower than those of the control infants. 3 of the 25 control infants (but none of the 25 treated infants) had bilirubin levels greater than 18 mg/100 ml (308 mumol/l) and required exchange transfusion. No sedation or drowsiness was observed in the infants given bucolome, and though the drug caused some vomiting, weight gains were unaffected.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1468-2044
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
549-50
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:18116-Barbiturates,
pubmed-meshheading:18116-Clinical Trials as Topic,
pubmed-meshheading:18116-Female,
pubmed-meshheading:18116-Humans,
pubmed-meshheading:18116-Infant, Newborn,
pubmed-meshheading:18116-Infant, Premature, Diseases,
pubmed-meshheading:18116-Jaundice, Neonatal,
pubmed-meshheading:18116-Male
|
pubmed:year |
1977
|
pubmed:articleTitle |
Bucolome in prevention of hyperbilirubinaemia in preterm infants.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|